Schedule 13D ownership disclosure

Aura Biosciences Inc

Common Stock, par value $0.00001 per share · CUSIP: 05153U107

Event date: 2025-05-16

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Matrix Capital Management Company LPReported CIK 0001410830

    Shares: 6,922,870.00 · Class: 11.17%

  • David E. GoelReported CIK 0001548144

    Shares: 6,922,870.00 · Class: 11.17%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002479
Form type
SCHEDULE 13D/A
Filer
Aura Biosciences, Inc.
CIK
CIK 1501796
Filed
May 19, 2025
Reporting period
May 16, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub